Dr Martens backs FY guidance, on track to meet strategic objectives

(Sharecast News) - Iconic bootmaker Dr Martens backed its full-year guidance on Wednesday ahead of its annual general meeting, and said it was on track with its strategic objectives. In a brief statement, the company said trading since the start of this financial year has been in line with expectations and its outlook and guidance for FY27 are unchanged.

"We are focused on our ambition to become the world's most-desired premium footwear brand and are on track with our strategic objectives for FY27, as shared in our results on 19th May," it said.

This includes driving full-price revenue mix in the UK and DACH (Germany, Austria and Switzerland), successfully introducing an "innovative" new sandals range and launching new retail concepts in key cities globally.

Dr Martens said the US - its largest market - continues to grow, with wholesale particularly encouraging. The company's largest Asian markets, Japan and South Korea, are both performing well, while its European markets are performing as expected "against a challenging consumer backdrop", it said.

At 0920 BST, the shares were up 1.1% at 73.50p.

See latest RNS on Investegate